Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
July 1987
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1987
Report date:
1987

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
yes
Remarks:
: only 4 strains, no strains with AT base pair at the primary reversion site, culture media used not reported
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
Sodium fluoride
EC Number:
231-667-8
EC Name:
Sodium fluoride
Cas Number:
7681-49-4
Molecular formula:
NaF
IUPAC Name:
sodium fluoride
Details on test material:
- Name of test material (as cited in study report): NaF
- Molecular formula (if other than submission substance): NaF
- Molecular weight (if other than submission substance): 42 g/mol
- Physical state: solid (white powder)
- Analytical purity: 99.4%
- Purity test date: May 5, 1987
- Lot/batch No.: 26061987 (internal)
- Stability under test conditions: aqueous suspensions of NaF are stable under the experimental conditions. According to the sponsor, the compound is stable for storage for at least the test period.
- Storage condition of test material: refrigerator

Method

Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Additional strain / cell type characteristics:
other: partly deficient in lipopolysaccharide side chains of their cell walls, UV repair ability malfunctions
Metabolic activation:
with and without
Metabolic activation system:
S9 mix
Test concentrations with justification for top dose:
first test: 0, 20, 100, 500, 2500, 12500 µg per plate
repeat test: 0, 375, 750, 1500, 3000, 6000, 12000 µg per plate
Vehicle / solvent:
the solvent used for NaF was demineralized water, and for the positive controls DMSO
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: -S9: sodium azide (only TA 1535), nitrofurantoin (only TA 100), 4-nitro-1,2-phenylenediamine (TA 1537 + TA 98), +S9: 2-aminoanthracene
Remarks:
no
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation)


DURATION
- Exposure duration: 48 h




NUMBER OF REPLICATIONS:
four plates per strain and dose, both with and without S-9 mix, were used for mutant count. Four plates per strain were also used for each positive control.




DETERMINATION OF CYTOTOXICITY
- other: background growth on the plates for the mutant determination; toxic effect assumed when mutant count per plate was clearly lower than the negative control count in dose correlation; determination of titer



Evaluation criteria:
A reproducible and dose-related increase (ie. at least twice the negative control count) in mutant counts for at least one strain was considered positive.
In the case of no reproducible and dose-related increase in mutant counts in at least one strain, the result was evaluated as negative.
In the case of questionable results, the investigations continued, probably by the use of modifications, until a final evaluation was possible.

Results and discussion

Test results
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
: Doses up to and including 6000 µg per plate did not cause any bacteriotoxic effects. At higher doses, the substance had only a weak bacteriotoxic effect in TA 1535 and TA 100, so that this range could nevertheless be used for evaluation purposes.
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Remarks on result:
other: strain/cell type: S. typhimurium TA1535, TA100, TA1537, TA98
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

None of the four strains used showed a dose-related and biologically relevant increase in mutant counts over those of the negative controls. This applied both to the tests with and without S-9 mix and was confirmed by the results of the repeat tests.

 

Table 1. Summary of the results of the Ames test on NaF without S-9 mix

 

TA 1535

TA 100

TA 1537

TA 98

Test/doses
µg/plate

Means
revertantsper plate

Titer per ml 108

Quotient

Means
revertantsper plate

Titer per ml 108

Quotient

Means
revertantsper plate

Titer per ml 108

Quotient

Means
revertantsper plate

Titer per ml 108

Quotient

1sttest

0

11

30.8

1.0

61

6.4

1.0

7

37.6

1.0

16

56.0

1.0

20

11

24.4

1.0

72

7.7

1.2

7

33.7

1.0

16

58.0

1.0

100

9

27.7

0.8

74

7.9

1.2

6

35.1

0.9

23

64.6

1.4

500

10

35.3

0.9

71

12.9

1.2

5

34.1

0.6

16

53.0

1.0

2500

9

35.1

0.8

67

12.6

1.1

6

35.3

0.8

19

54.3

1.2

12500

9

17.9**

0.8

69

7.2

1.1

5

32.9

0.7

17

66.8

1.0

Na-Azide

601

36.4

55.9*

 

 

 

 

 

 

 

 

 

NF

 

 

 

217

9.1

3.6*

 

 

 

 

 

 

4-NPDA

 

 

 

 

 

 

48

34.8

6.6*

93

59.6

5.7*

2-AA (+S9)

 

38.7

 

 

11.9

 

 

34.6

 

 

49.4

 

2ndtest

0

14

48.6

1.0

64

20.9

1.0

7

50.8

1.0

17

62.0

1.0

375

15

45.7

1.1

57

11.3

0.9

6

47.8

0.9

14

65.2

0.9

750

13

49.2

0.9

62

9.9

1.0

5

39.2

0.7

19

63.9

1.1

1500

12

48.2

0.9

56

10.4

0.9

8

48.5

1.3

18

67.6

1.1

3000

16

46.1

1.1

66

10.0

1.0

8

47.6

1.2

20

69.2

1.2

6000

14

51.3

1.0

67

10.1

1.0

5

49.4

0.8

15

73.8

0.9

12000

15

26.1**

1.1

77

7.4

1.2

5

45.7

0.8

15

80.0

0.9

Na-Azide

922

49.9

67.0*

 

 

 

 

 

 

 

 

 

NF

 

 

 

257

13.2

4.0*

 

 

 

 

 

 

4-NPDA

 

 

 

 

 

 

68

57.8

10.4*

130

53.5

7.7*

2-AA (+S9)

 

54.8

 

 

13.3

 

 

58.1

 

 

58.3

 

 

Na-Azide: Sodium azide, 10 µg/plate

NF: Nitrofurantoin, 0.2 µg/plate

4-NPDA: 4-nitro-1,2-phenylenediamine, 0.5 µg/plate

2-AA: 2-aminoanthracene, 3 µg/plate

 

* = mutagenic effect

** =bacteriotoxic effect

 

 

Table 2. Summary of the results of the Ames test on NaF with S-9 mix

 

TA 1535

TA 100

TA 1537

TA 98

Test/doses
µg/plate

Means
revertantsper plate

Quotient

Means
revertantsper plate

Quotient

Means
revertantsper plate

Quotient

Means
revertantsper plate

Quotient

1sttest

 

 

 

 

 

 

 

 

0

15

1.0

132

1.0

8

1.0

44

1.0

20

17

1.1

122

0.9

8

1.0

35

0.8

100

16

1.1

107

0.8

8

1.0

33

0.7

500

19

1.3

128

1.0

9

1.1

29

0.7

2500

19

1.3

85

0.6

6

0.8

45

1.0

12500

18

1.2

48**

0.4

4

0.5

35

0.8

2-AA

143

9.7*

395

3.0*

27

3.5*

373

8.6*

2ndtest

 

 

 

 

 

 

 

 

0

23

1.0

104

1.0

9

1.0

49

1.0

375

28

1.2

105

1.0

10

1.1

43

0.9

750

25

1.1

128

1.2

11

1.3

36

0.7

1500

19

0.8

108

1.0

7

0.8

42

0.9

3000

24

1.0

133

1.3

7

0.8

53

1.1

6000

20

0.9

132

1.3

8

0.9

36

0.7

12000

20

0.8

102

1.0

6

0.7

32

0.7

2-AA

235

10.1*

540

5.2*

43

5.0*

634

13.1*

 

2-AA: 2-aminoanthracene,3 µg/plate

 

* = mutagenic effect

** =bacteriotoxic effect

 

Applicant's summary and conclusion

Conclusions:
Interpretation of results:
negative without metabolic activation
negative with metabolic activation
Executive summary:

Herbold BA (1987)

NaF (as a surrogate for fluorosulphuric acid) was investigated in a Salmonella / microsome test for point-mutagenic effects in doses up to 12500 µg per plate on four Salmonella typhimurium LT2 mutants with and without metabolic activation. Test was performed similar to the OECD guideline 471 with restrictions (Only four strains, no strains with AT base pair as primary reversion site. Different positive control substances used in comparison with OECD guideline. Culture media used: not reported).

For the test the histidine-auxotrophic strains TA 1535, TA 100, TA 1537 and TA 98 were used.

Doses up to and including 6000 µg per plate did not cause any bacteriotoxic effects. The total bacteria counts remained unchanged. No inhibition of growth was observed.

At higher doses, the substance had only a bacteriotoxic effect in TA 1535 and TA 100, so that this range could nevertheless be used for evaluation purposes. Substance precipitation occurred from the dose 500 µg per plate.

Evidence of mutagenic activity for NaF was not found with and without metabolic activation. Neither a dose-related doubling of the mutant count nor a biologically relevant increase in the same, was observed in comparison with the negative controls.

The positive controls sodium azide (Na-azide) , nitrofurantoin (NF), 4-nitro-1,2-phenylene-diamine (4-NPDA),  and 2-aminoanthracene (2 -AA) had a marked mutagenic effect, as can be seen from the biologically relevant increase in mutant colonies, compared to the corresponding negative controls.